Latest Breaking News On - Securities biomed forum - Page 1 : comparemela.com

ORYZON to Provide Corporate Progress Updates at Several Events in January

ORYZON to Provide Corporate Progress Updates at Several Events in January
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesComunidad autonoma de catalunaSan diegoSachs annual neuroscience innovation forumMarine memorial clubFox chase cancer centerHilton union squareFrancis hotelUs national cancer instituteDevelopment agreementNeuro psychiatric disorders panelSecurities biomed forumBeacon grand hotelProvide corporate progress updatesSeveral eventsSachs annual neuroscience innovation

Transgene Announces Upcoming Investor Meetings

Transgene Announces Upcoming Investor Meetings
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

France generalSan franciscoUnited statesLucie larguierTransgene euronextStefan klotterFrazer hall sylvie berrebiSecurities biomed forum parisCorporate communicationsRegulatory newsAnnual lifesci advisors corporate access eventSecurities biomed forumArtificial intelligenceSylvie berrebiLassen sie

GENFIT to Participate in Upcoming Investor Conferences

Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland) January 5, 2023 – GENFIT (Nasdaq and Euronext: GNFT), a late-stage.

United statesFrance generalUnited kingdomNoord hollandSan franciscoStephanie boyerSecurities biomed forumExchange commissionUncertainties of the companyAccess eventsGlobal biopharmaGlobal biopharma conference fireside chatInvestor relationsPipeline dayNasdaq global select marketPrivate securities litigation reform act

GenSight Biologics to Present at Upcoming Investor Conferences

04.01.2023 - Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma Company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system .

France generalGensight biologicsThomas gidoinSecurities biomed forumInvest securities biomedChief financial officerDegroof petercam healthcareSight biologicMitochondrial targeting sequenceLeber hereditary optic neuropathyGensight biologicGensight biologics stock